Moderna, Inc. (MRNA) has a market capitalization of $20.87B and trades at $52.84. The 52-week range is 22.28-59.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.3, Earnings Per Share (EPS) of $-7.26, annual revenue of $1.94B.
The stock has a beta of 1.34, operates in the Healthcare sector.
